Deadly Staph Infections Fought Well With Antibiotics Combo

An international team of researchers has found that a combination of two antibiotics is effective in fighting pathogenic bacteria.

When it comes to fighting pathogenic bacteria, an international team of researchers has opined that a cocktail of two antibiotics would prove effective.

Individually, lankacidin and lankamycin, two antibiotics produced naturally by the microbe streptomyces, are marginally effective in warding off pathogens.

Novel Nanotechnology Heals Abscesses Caused by Resistant Staph Bacteria
Researchers have developed a new approach for treating and healing skin abscesses caused by bacteria resistant to most antibiotics.

However, when used together, the two antibiotics were much more successful in inhibiting growth of dangerous pathogens such as MRSA, or methicillin-resistant Staphylococcus aureus, and possibly others, says lead researcher Alexander Mankin, professor and associate director of the UIC Centre for Pharmaceutical Biotechnology.

"What we found most amazing is that the two antibiotics appeared to help each other in stopping pathogens from making new proteins and in inhibiting bacterial growth," said Mankin.

Lankacidin and lankamycin act upon the ribosomes, the protein-synthesizing factories of the cell.

Infections Caused by Staph Aureus More Lethal Than Earlier Thought
Staphylococcus aureus causes much more serious infections than previously believed, a new Swedish research has found.

A newly-made protein exits the ribosome through a tunnel through the ribosome body. Some antibiotics stave off an infection by preventing the ribosome from assembling proteins, while others bind in the tunnel and block the protein's passage.

Through the use of X-ray crystallography, which determines the arrangement of atoms in biological molecules, the Israeli team, led by Ada Yonath, a 2009 Nobel Prize winner, discovered the exact binding site of lankacidin in the ribosome. Mankin's group demonstrated that lankacidin prevents the ribosome from assembling new proteins.

US Sees Rise in Drug-Resistant Staph Infections
Cases of antibiotic-resistant staph infections usually acquired in the community are growing in the United States and rapidly spreading to hospitals, researchers said Tuesday.

When researchers realized that streptomyces also manufactures lankamycin, they became curious whether the two drugs might help each other.

Biochemical analysis and molecular modeling showed that ankamycin binds in the ribosomal tunnel right next to ankacidin.

Call For Mandatory Reporting Of Golden Staph Bloodstream Infections
Mandatory reporting of Staphylococcus aureus bacteraemia (bloodstream infections) should be introduced to help improved health care practices and save lives...

The study appears in online edition of the Proceedings of the National Academy of Sciences of the USA.

Source-ANI
TAN